Key facts
- This page summarizes Brett A. Pletcher's Form 4 filing for CYTOKINETICS INC (CYTK).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Sep 2024, 17:06.
Brett A. Pletcher - 30 Aug 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)
- Reporting relationship
- EVP, Chief Legal Officer
- Issuer ticker
- CYTK
- Reported as of
- 30 Aug 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Sep 2024, 17:06:12 UTC
- Prior SEC filing
- 19 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John O. Faurescu, attorney-in-fact for Mr. Pletcher
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Brett A. Pletcher filed Form 4 for CYTOKINETICS INC (CYTK) on 03 Sep 2024.
Change
- Previous filing in this sequence was filed on 19 Aug 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CYTK
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +33,140
- Change %
- Price
- $0.000000
- Shares after
- 33,140
- Date
- 30 Aug 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CYTK
transaction
Derivative
Non-Qualified Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +51,039
- Change %
- Price
- $0.000000
- Shares after
- 51,039
- Date
- 30 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,039
- Exercise price
- $57.08
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Inducement grant comprised of restricted stock units ("RSUs") that are converted into shares of common stock on a 1:1 basis upon time based vesting. 40% of the RSUs vest on the 1-year anniversary of the grant date, an additional 40% of the RSUs vest on the 2-year anniversary of the grant date, and the remaining 20% of the RSUs vest on the 3-year anniversary of the grant date, in each case subject to the grantee's continued employment with the company.
Footnote F2
Inducement grant comprised of stock options to purchase shares of common stock subject to time lapse vesting. 25% of the stock options vest on the 1-year anniversary of the grant date and the remaining 75% of the stock options vest in equal monthly installments over the subsequent 3 years to the 1-year anniversary of the grant date, with each installment vesting subject to the grantee's continued employment with the company.